2m 2m 2m 2m 2m 2m 2m
AMNEAL PHRMCTL-A (AMRX)
NASDAQ
$16.74+$0.07 (+0.45%)
Price as of Jun 23, 2026 7:49 PM EDT- $5.1BMarket Cap
- 103.54%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AMNEAL PHRMCTL-A (AMRX)
$16.74+$0.07 (+0.45%)
AMRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.66 | ||
Change | +$0.55 (+3.41%) | ||
Open | $16.00 | ||
High | $16.73 | ||
Low | $15.93 | ||
Previous Close | $16.11 | ||
Volume | 1,826,205 | ||
30-Day Average Volume | 2,025,719 | ||
1-Week Change | 2.52% | ||
1-Month Change | 34.14% | ||
1-Year Change | 104.92% | ||
3-Year Change | 478.47% | ||
5-Year Change | 216.73% | ||
Fundamentals | |||
Shares Outstanding | 319.0M | ||
Total Assets | $3.5B | ||
Market Cap | $5.1B | ||
Enterprise Value | $7.5B | ||
Period: QTR TTM FY | |||
Revenue | $722.5M | ||
Net Income | $62.3M | ||
Free Cash Flow | -$34.9M | ||
EBIT | $117.8M | ||
EBITDA | $147.8M | ||
Net Working Capital | $1.1B | ||
EPS | $0.19 | ||
Enterprise Value/EBITDA | 51 | ||
Enterprise Value/Revenue | 10 | ||
P/B | -113 | ||
P/E | 85 | ||
PEG | 1 | ||
Price/Free Cash Flow | -147 | ||
Price/Operating Cash Flow | -192 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/26/2013 | ||
Earnings & Revenue